Researchers reveal details about the first cat infected with SARS-CoV-2 in Spain
The Institute of Agrifood Research and Technology (IRTA) reported the case of the first cat infected with SARS-CoV-2 in Spain. It was a 4-year-old...
Research identifies 21 existing drugs that could treat COVID-19
A Nature study authored by a global team of scientists and led by Sumit Chanda, Ph.D., professor at Sanford Burnham Prebys Medical Discovery Institute,...
Fitness Program improves quality of life
Older adults experienced less pain, reduced stiffness and less fatigue after participating in a hospital-based exercise program, researchers report. "The study adds to the...
Study finds ‘Dr. Google’ is almost always wrong
Many people turn to 'Dr Google' to self-diagnose their health symptoms and seek medical advice, but online symptom checkers are only accurate about a...
Study: The many ways the Sexual Violence Resource Centre offers help
In order to fulfill the commitment to maintaining a safe and respectful work and learning environment, the University of Manitoba actively listens to the...
Study: Warning for children with chronic conditions
With stressed hospital services, and concerns about the spread of COVID-19, experts are reminding carers of children and young people of the importance of...
Study: “Love hormone” oxytocin could be used to treat cognitive disorders like Alzheimer’s
Alzheimer's disease is a progressive disorder in which the nerve cells (neurons) in a person's brain and the connections among them degenerate slowly, causing...
Study: Thyroid inflammation linked to anxiety disorders
Patients with autoimmune inflammation of their thyroid may be at greater risk of developing anxiety, according to a study being presented at e-ECE 2020....
Study: Receptor makes mice strong and slim
Increasing abdominal girth and shrinking muscles are two common side effects of aging. Researchers at the University of Bonn have discovered a receptor in...
Study: PARPi olaparib for the targeted treatment of metastatic prostate cancer
Results from the PROfound phase III study, funded by AstraZeneca and Merck Sharp & Dohme, open up a much-needed new treatment avenue for the...